| CAS No.: | 26447-85-8 |
|---|---|
| Formula: | C11h10o3s2 |
| Type: | Pharmaceutical Intermediates |
| Appearance: | Powder |
| Quality: | Technical |
| Colour: | White |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier Cholinesterase Inhibition:
One of the primary functions of MDG is its ability to inhibit cholinesterase enzymes, particularly acetylcholinesterase (AChE). By inhibiting AChE, MDG derivatives can increase the concentration of acetylcholine, a neurotransmitter involved in cognitive functions. This function is especially relevant in the treatment of neurodegenerative diseases, such as Alzheimer's disease, where the reduction of acetylcholine levels contributes to cognitive impairment. MDG's cholinesterase inhibitory activity plays a crucial role in potential drug development for these conditions.
Neuroprotection:
In addition to its cholinesterase inhibition, MDG has shown neuroprotective properties in preclinical studies. It has been reported to have antioxidant and anti-inflammatory effects, which may help prevent or mitigate neuronal damage. These neuroprotective functions make MDG a promising candidate for developing drugs aimed at preserving cognitive function and reducing neurodegeneration.
Organic Synthesis:
MDG is widely used as a building block in organic synthesis due to its ability to undergo various transformations and reactions. Its thienyl groups can participate in cross-coupling reactions, including Suzuki-Miyaura and Heck reactions, allowing the introduction of diverse functional groups into organic molecules. The glycolate moiety can act as a precursor for alcohol, amine, or ester functionalities, expanding the synthetic possibilities of MDG. Its synthetic versatility makes MDG an invaluable tool for creating complex molecules in the pharmaceutical and agrochemical industries.
Pharmaceutical Applications:
MDG has gained significant attention in the pharmaceutical field due to its potential therapeutic properties. Several studies have explored its use as a drug candidate for the treatment of various diseases. One notable application is its potential role in neurological disorders, particularly Alzheimer's disease. MDG derivatives have demonstrated cholinesterase inhibitory activity, which is important for enhancing cholinergic transmission, a key mechanism in Alzheimer's disease treatment. Further research and development of MDG derivatives hold promise for the development of new therapeutic agents in the future.
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}